ArticleCardiovascular endocrinology & metabolism2023

The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists.

Kazuo Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.